Lixte Biotech Hldgs Q4 EPS $(0.34) Down From $(0.27) YoY

Benzinga Newsdesk www.benzinga.com Negative 97.2%

Neg 97.2% Neu 0% Pos 0%

Lixte Biotech Hldgs (NASDAQ:LIXT) reported quarterly losses of $(0.34) per share. This is a 25.93 percent decrease over losses of $(0.27) per share from the same period last year.